Homology Medicines Stock Fundamentals
| FIXXDelisted Stock | USD 1.09 0.06 5.83% |
Homology Medicines fundamentals help investors to digest information that contributes to Homology Medicines' financial success or failures. It also enables traders to predict the movement of Homology Stock. The fundamental analysis module provides a way to measure Homology Medicines' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Homology Medicines stock.
Homology |
Homology Medicines Company Operating Margin Analysis
Homology Medicines' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Homology Medicines Operating Margin | (78.85) % |
Most of Homology Medicines' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Homology Medicines is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Homology Medicines has an Operating Margin of -78.8495%. This is 124.77% higher than that of the Biotechnology sector and 29.64% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Homology Medicines Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Homology Medicines's current stock value. Our valuation model uses many indicators to compare Homology Medicines value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Homology Medicines competition to find correlations between indicators driving Homology Medicines's intrinsic value. More Info.Homology Medicines is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Homology Medicines' earnings, one of the primary drivers of an investment's value.Homology Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Homology Medicines' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Homology Medicines could also be used in its relative valuation, which is a method of valuing Homology Medicines by comparing valuation metrics of similar companies.Homology Medicines is currently under evaluation in operating margin category among its peers.
Homology Fundamentals
| Return On Equity | -0.9 | |||
| Return On Asset | -0.36 | |||
| Operating Margin | (78.85) % | |||
| Current Valuation | (27 M) | |||
| Shares Outstanding | 3.23 M | |||
| Shares Owned By Insiders | 9.20 % | |||
| Shares Owned By Institutions | 46.75 % | |||
| Number Of Shares Shorted | 338.72 K | |||
| Price To Earning | (10.00) X | |||
| Price To Book | 0.04 X | |||
| Price To Sales | 2.61 X | |||
| Revenue | 1.16 M | |||
| Gross Profit | (95.14 M) | |||
| EBITDA | (91.52 M) | |||
| Net Income | (112.96 M) | |||
| Cash And Equivalents | 201.07 M | |||
| Cash Per Share | 3.50 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 8.44 X | |||
| Book Value Per Share | 22.65 X | |||
| Cash Flow From Operations | (96.23 M) | |||
| Short Ratio | 0.62 X | |||
| Earnings Per Share | (35.10) X | |||
| Price To Earnings To Growth | 21.38 X | |||
| Target Price | 1.5 | |||
| Beta | -0.11 | |||
| Market Capitalization | 3.02 M | |||
| Total Asset | 306.12 M | |||
| Retained Earnings | (542.1 M) | |||
| Working Capital | 72.34 M | |||
| Current Asset | 48.82 M | |||
| Current Liabilities | 8.27 M | |||
| Net Asset | 306.12 M |
About Homology Medicines Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Homology Medicines's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Homology Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Homology Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. Homology Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 224 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |